Bruker (BRKR) EBIT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,482.00 |
| Dec 31, 2025 | -2,110.00 |
| Sep 30, 2025 | -2,190.00 |
| Jun 30, 2025 | -743.00 |
| Mar 31, 2025 | 10.00 |
| Dec 31, 2024 | -1,226.00 |
| Sep 30, 2024 | -897.00 |
| Jun 30, 2024 | -491.00 |
| Mar 31, 2024 | -10.00 |
| Dec 31, 2023 | -711.00 |
| Sep 30, 2023 | 195.00 |
| Jun 30, 2023 | 164.00 |
| Mar 31, 2023 | 908.00 |
| Dec 31, 2022 | 53.00 |
| Sep 30, 2022 | 877.00 |
| Jun 30, 2022 | 405.00 |
| Mar 31, 2022 | 645.00 |
| Dec 31, 2021 | 200.00 |
| Sep 30, 2021 | 694.00 |
| Jun 30, 2021 | 951.00 |
| Mar 31, 2021 | 701.00 |
| Dec 31, 2020 | 319.00 |
| Sep 30, 2020 | 876.00 |
| Jun 30, 2020 | 95.00 |
| Mar 31, 2020 | -43.00 |
| Dec 31, 2019 | 1,086.00 |
| Sep 30, 2019 | 1,568.00 |
| Jun 30, 2019 | 317.00 |
| Mar 31, 2019 | 422.00 |
| Dec 31, 2018 | 817.00 |
| Sep 30, 2018 | 763.00 |
| Jun 30, 2018 | 144.00 |
| Mar 31, 2018 | 572.00 |
| Dec 31, 2017 | 1,039.00 |
| Sep 30, 2017 | -169.00 |
| Jun 30, 2017 | 325.00 |
| Mar 31, 2017 | 129.00 |
| Dec 31, 2016 | 505.00 |
| Sep 30, 2016 | 269.00 |
| Jun 30, 2016 | -416.00 |
| Mar 31, 2016 | 186.00 |
| Dec 31, 2015 | 238.00 |
| Sep 30, 2015 | -555.00 |
| Jun 30, 2015 | -462.00 |
| Mar 31, 2015 | -539.00 |